Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
Open accessThe DOI matches its Crossref record; 213 of the 213 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The objective is to formulate clinical practice guidelines for treating Cushing's syndrome. PARTICIPANTS: Participants include an Endocrine Society-appointed Task Force of experts, a methodologist, and a medical writer. The European Society for Endocrinology co-sponsored the guideline. EVIDENCE: The Task Force used the Grading of Recommendations, Assessment, Development, and Evaluation system to describe the strength of recommendations and the quality of evidence. The Task Force commissioned three systematic reviews and used the best available evidence from other published systematic reviews and individual studies. CONSENSUS PROCESS: The Task Force achieved consensus through one group meeting, several conference calls, and numerous e-mail communications. Committees and members of The Endocrine Society and the European Society of Endocrinology reviewed and commented on preliminary drafts of these guidelines. CONCLUSIONS: Treatment of Cushing's syndrome is essential to reduce mortality and associated comorbidities. Effective treatment includes the normalization of cortisol levels or action. It also includes the normalization of comorbidities via directly treating the cause of Cushing's syndrome and by adjunctive treatments (eg, antihypertensives). Surgical resection of the causal lesion(s) is generally the first-line approach. The choice of second-line treatments, including medication, bilateral adrenalectomy, and radiation therapy (for corticotrope tumors), must be individualized to each patient.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The guidelines provide a general definition of remission after resection of an ACTH-producing corticotroph tumor as morning serum cortisol levels <5 μg/dL (<138 nmol/L) or UFC <28-56 nmol/d (<10-20 μg/d) within 7 days of tumor resection (37).”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [37]
In the citing paper
“Steroidogenesis inhibitors work by inhibiting one or more enzymes involved in steroidogenesis, decreasing cortisol and other steroid hormone production (37, 38).”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [37]
In the citing paper
“Available medical therapies currently used in clinical practice to treat CS include medications from 3 classes: pituitary-directed therapies (for pituitary CD only), steroidogenesis inhibitors, and glucocorticoid receptor antagonists (37).”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [37]
In the citing paper
“In patients with CS, surgical resection of the causative lesion(s) is the first-line treatment option regardless of etiology.”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [37]
In the citing paper
“Pituitary-directed therapies, including pasireotide (US/EU/Canada) and cabergoline (off-label use only), inhibit pituitary ACTH production and, in some cases, ectopic ACTH secretion from neuroendocrine tumors, thereby reducing downstream cortisol secretion (37, 128).”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [37]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718 · cited 2×
“(17) 2810 Nieman et al Guidelines on Cushing’s Syndrome Treatment J Clin Endocrinol Metab, August 2015, 100(8):2807–2831”
BackgroundSelf-citationKahn (2012) · doi:10.1378/chest.11-2296 · Cited by 2,693
Self-citationPrevention of VTE in Nonorthopedic Surgical Patients
Gould, M. K., Garcia, D. A., Wren, S. M., Karanicolas, P. J., Arcelus, J. I., Heit, J. A., & Samama, C. M. (2012) · Chest · doi:10.1378/chest.11-2297 · Cited by 2,131
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Self-citationMolitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0179 · Cited by 1,047
Cushing, H. (1964) · Journal of Neurosurgery · doi:10.3171/jns.1964.21.4.0318 · Cited by 851
Starkman, M. N., Gebarski, S. S., Berent, S., & Schteingart, D. E. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90079-f · Cited by 840
The natural history of cushing's syndrome
Plotz, C. M., Knowlton, A. I., & Ragan, C. (1952) · The American Journal of Medicine · doi:10.1016/0002-9343(52)90027-2 · Cited by 763
Cited by
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
Umemura, S., Arima, H., Arima, S., Asayama, K., Dohi, Y., Hirooka, Y., Horio, T., Hoshide, S., Ikeda, S., Ishimitsu, T., et al. (2019) · Hypertension Research · doi:10.1038/s41440-019-0284-9 · Cited by 1,880
Fassnacht, M., Arlt, W., Bancos, I., Dralle, H., Newell-Price, J., Sahdev, A., Tabarin, A., Terzolo, M., Tsagarakis, S., & Dekkers, O. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0467 · Cited by 1,566
Self-citationCarey, R. M., Calhoun, D. A., Bakris, G. L., Brook, R. D., Daugherty, S. L., Dennison-Himmelfarb, C. R., Egan, B. M., Flack, J. M., Gidding, S. S., Judd, E., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000084 · Cited by 1,153
Diretrizes Brasileiras de Hipertensão Arterial – 2020
Barroso, W. K. S., Rodrigues, C. I. S., Bortolotto, L. A., Mota-Gomes, M. A., Brandão, A. A., Feitosa, A. D. D. M., Machado, C. A., Poli-de-Figueiredo, C. E., Amodeo, C., Mion, D., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20201238 · Cited by 1,068
Fassnacht, M., Dekkers, O. M., Else, T., Baudin, E., Berruti, A., de Krijger, R. R., Haak, H. R., Mihai, R., Assie, G., & Terzolo, M. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0608 · Cited by 961
Consensus on diagnosis and management of Cushing's disease: a guideline update
Fleseriu, M., Auchus, R., Bancos, I., Ben-Shlomo, A., Bertherat, J., Biermasz, N. R., Boguszewski, C. L., Bronstein, M. D., Buchfelder, M., Carmichael, J. D., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00235-7 · Cited by 953
Self-citationHormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
Self-citationDiagnosis and Treatment of Pituitary Adenomas: A Review
Molitch, M. E. (2017) · JAMA · doi:10.1001/jama.2016.19699 · Cited by 933
Fassnacht, M., Tsagarakis, S., Terzolo, M., Tabarin, A., Sahdev, A., Newell-Price, J., Pelsma, I., Marina, L., Lorenz, K., Bancos, I., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad066 · Cited by 786
Self-citationComplications of Cushing's syndrome: state of the art
Pivonello, R., Isidori, A. M., De Martino, M. C., Newell-Price, J., Biller, B. M. K., & Colao, A. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00086-3 · Cited by 641
Self-citationNeuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Shah, M. H., Goldner, W. S., Benson, A. B., Bergsland, E., Blaszkowsky, L. S., Brock, P., Chan, J., Das, S., Dickson, P. V., Fanta, P., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0032 · Cited by 619
Pituitary-Tumor Endocrinopathies
Melmed, S. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1810772 · Cited by 604
Raverot, G., Burman, P., McCormack, A., Heaney, A., Petersenn, S., Popovic, V., Trouillas, J., Dekkers, O. M., & _, _. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0796 · Cited by 595
Diagnosis and Management of Pituitary Adenomas: A Review
Tritos, N. A., & Miller, K. K. (2023) · JAMA · doi:10.1001/jama.2023.5444 · Cited by 331
Hair cortisol analysis: An update on methodological considerations and clinical applications
Greff, M. J. E., Levine, J. M., Abuzgaia, A. M., Elzagallaai, A. A., Rieder, M. J., & van Uum, S. H. M. (2019) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2018.09.010 · Cited by 260
Reincke, M., & Fleseriu, M. (2023) · JAMA · doi:10.1001/jama.2023.11305 · Cited by 256
Guideline panels should seldom make good practice statements: guidance from the GRADE Working Group
Guyatt, G. H., Alonso-Coello, P., Schünemann, H. J., Djulbegovic, B., Nothacker, M., Lange, S., Murad, M. H., & Akl, E. A. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.07.006 · Cited by 243
Self-citationYoung, J., Haissaguerre, M., Viera-Pinto, O., Chabre, O., Baudin, E., & Tabarin, A. (2020) · European Journal of Endocrinology · doi:10.1530/eje-19-0877 · Cited by 232
Self-citationPivonello, R., Fleseriu, M., Newell-Price, J., Bertagna, X., Findling, J., Shimatsu, A., Gu, F., Auchus, R., Leelawattana, R., Lee, E. J., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30240-0 · Cited by 222
Self-citationCushing's disease: pathobiology, diagnosis, and management
Lonser, R. R., Nieman, L., & Oldfield, E. H. (2017) · Journal of Neurosurgery · doi:10.3171/2016.1.jns152119 · Cited by 215
Self-citationICAR: endoscopic skull‐base surgery
Wang, E. W., Zanation, A. M., Gardner, P. A., Schwartz, T. H., Eloy, J. A., Adappa, N. D., Bettag, M., Bleier, B. S., Cappabianca, P., Carrau, R. L., et al. (2019) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22326 · Cited by 209
Aggressive pituitary tumours and pituitary carcinomas
Raverot, G., Ilie, M. D., Lasolle, H., Amodru, V., Trouillas, J., Castinetti, F., & Brue, T. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00550-w · Cited by 194
Mazziotti, G., Frara, S., & Giustina, A. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00005 · Cited by 181
Cushing’s disease: the burden of illness
Pivonello, R., De Martino, M. C., De Leo, M., Simeoli, C., & Colao, A. (2017) · Endocrine · doi:10.1007/s12020-016-0984-8 · Cited by 171
Gadelha, M., Gatto, F., Wildemberg, L. E., & Fleseriu, M. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01961-x · Cited by 168
Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial
Lacroix, A., Gu, F., Gallardo, W., Pivonello, R., Yu, Y., Witek, P., Boscaro, M., Salvatori, R., Yamada, M., Tauchmanova, L., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30326-1 · Cited by 162
Self-citationCurrent best practice in the management of patients after pituitary surgery
Prete, A., Corsello, S. M., & Salvatori, R. (2017) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018816687240 · Cited by 154
Clinical guidelines for the management of adrenal incidentaloma
Lee, J.-M., Kim, M. K., Ko, S.-H., Koh, J.-M., Kim, B.-Y., Kim, S. W., Kim, S.-K., Kim, H. J., Ryu, O.-H., Park, J., et al. (2017) · Endocrinology and Metabolism · doi:10.3803/enm.2017.32.2.200 · Cited by 147
Psychiatric Symptoms in Patients with Cushing’s Syndrome: Prevalence, Diagnosis and Management
Vives, A. S., Resmini, E., Pascual, J. C., Crespo, I., & Webb, S. M. (2017) · Drugs · doi:10.1007/s40265-017-0735-z · Cited by 146
Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials
Pivonello, R., Ferrigno, R., Martino, M. C. D., Simeoli, C., Paola, N. D., Pivonello, C., Barba, L., Negri, M., de Angelis, C., & Colao, A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00648 · Cited by 147
Lopez, D., Luque-Fernandez, M. A., Steele, A., Adler, G. K., Turchin, A., & Vaidya, A. (2016) · Annals of Internal Medicine · doi:10.7326/m16-0547 · Cited by 145
Selective Progesterone Receptor Modulators—Mechanisms and Therapeutic Utility
Islam, M. S., Afrin, S., Jones, S. I., & Segars, J. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa012 · Cited by 143
Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management
Scaroni, C., Zilio, M., Foti, M., & Boscaro, M. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1105 · Cited by 140
Overall and Disease-Specific Mortality in Patients With Cushing Disease: A Swedish Nationwide Study
Ragnarsson, O., Olsson, D. S., Papakokkinou, E., Chantzichristos, D., Dahlqvist, P., Segerstedt, E., Olsson, T., Petersson, M., Berinder, K., Bensing, S., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02524 · Cited by 134
Cohen-Cohen, S., Gardner, P. A., Alves-Belo, J. T., Truong, H., Snyderman, C. H., Wang, E. W., & Fernandez-Miranda, J. C. (2018) · Journal of neurosurgery · doi:10.3171/2018.5.jns18595 · Cited by 131
Wagner, J., Langlois, F., Lim, D. S. T., McCartney, S., & Fleseriu, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00805 · Cited by 120
Shared decision making in endocrinology: Present and future directions
Rodriguez-Gutierrez, R., Gionfriddo, M. R., Ospina, N. S., Maraka, S., Tamhane, S., Montori, V. M., & Brito, J. P. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00468-4 · Cited by 117
Cushing’s Syndrome in Pediatrics
Lodish, M. B., Keil, M. F., & Stratakis, C. A. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2018.02.008 · Cited by 116
Outcomes of pituitary surgery for Cushing’s disease: a systematic review and meta-analysis
Stroud, A., Dhaliwal, P., Alvarado, R., Winder, M. J., Jonker, B., Grayson, J. W., Hamizan, A. K. W., Harvey, R. J., & McCormack, A. I. (2020) · Pituitary · doi:10.1007/s11102-020-01066-8 · Cited by 116
Cabergoline for Cushing’s disease: a large retrospective multicenter study
Ferriere, A., Cortet, C., Chanson, P., Delemer, B., Caron, P., Chabre, O., Reznik, Y., Bertherat, J., Rohmer, V, Briet, C., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0662 · Cited by 115
Self-citationRandomized trial of osilodrostat for the treatment of Cushing disease
Gadelha, M., Bex, M., Feelders, R. A., Heaney, A. P., Auchus, R. J., Gilis-Januszewska, A., Witek, P., Belaya, Z., Yu, Y., Liao, Z., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac178 · Cited by 114
Stereotactic Radiosurgery for Cushing Disease: Results of an International, Multicenter Study
Mehta, G. U., Ding, D., Patibandla, M. R., Kano, H., Sisterson, N. D., Su, Y.-H., Kršek, M., Nabeel, A. M., El-Shehaby, A. M. N., Abdelkarim, K., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01385 · Cited by 112
Kulle, A., Krone, N., Holterhus, P. M., Schuler, G., Greaves, R. F., Juul, A., de Rijke, Y. B., Hartmann, M. F., Saba, A., Hiort, O., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0953 · Cited by 111
Hines, J. M., Bancos, I., Bancos, C., Singh, R. D., Avula, A. V., Young, W. F., Grebe, S. K., & Singh, R. J. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.271106 · Cited by 111
Non-invasive Diagnostic Strategy in ACTH-dependent Cushing’s Syndrome
Frete, C., Corcuff, J.-B., Kuhn, E., Salenave, S., Gaye, D., Young, J., Chanson, P., & Tabarin, A. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa409 · Cited by 110
Self-citationZhang, F., Zhang, Q., Zhu, J., Yao, B., Ma, C., Qiao, N., He, S., Ye, Z., Wang, Y., Han, R., et al. (2022) · Cell Research · doi:10.1038/s41422-022-00736-5 · Cited by 110
Paraneoplastic endocrine syndromes
Dimitriadis, G. K., Angelousi, A. G., Weickert, M. O., Randeva, H. S., Kaltsas, G., & Grossman, A. B. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0036 · Cited by 108
Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practice
Brandi, M. L., Pieterman, C. R. C., English, K. A., Lines, K. E., Shariq, O. A., Marini, F., Cuny, T., Lewis, M. A., Stratakis, C. A., Perrier, N. D., et al. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00119-6 · Cited by 110
SIMBA: using Kolb’s learning theory in simulation-based learning to improve participants’ confidence
Davitadze, M., Ooi, E., Ng, C. Y., Zhou, D., Thomas, L., Hanania, T., Blaggan, P., Evans, N., Chen, W., Melson, E., et al. (2022) · BMC Medical Education · doi:10.1186/s12909-022-03176-2 · Cited by 107
Popoviciu, M. S., Păduraru, L., Nutas, R. M., Ujoc, A. M., Yahya, G., Metwally, K. A., & Cavalu, S. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612676 · Cited by 106
Ohya, Y., Arakawa, K., Arata, N., Arima, S., Arima, H., Asayama, K., Dohi, Y., Fukami, A., Furuhashi, M., Goto, K., et al. (2026) · Hypertension Research · doi:10.1038/s41440-025-02462-y · Cited by 107
The Pathophysiology and Treatment of Hypertension in Patients With Cushing's Syndrome
Barbot, M., Ceccato, F., & Scaroni, C. M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00321 · Cited by 104
Fleseriu, M., Pivonello, R., Elenkova, A., Salvatori, R., Auchus, R. J., Feelders, R. A., Geer, E. B., Greenman, Y., Witek, P., Cohen, F., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30313-4 · Cited by 101
Self-citationEffectiveness of medical treatment for Cushing’s syndrome: a systematic review and meta-analysis
Broersen, L. H. A., Jha, M., Biermasz, N. R., Pereira, A. M., & Dekkers, O. M. (2018) · Pituitary · doi:10.1007/s11102-018-0897-z · Cited by 100
Bertherat, J. Y., Bourdeau, I., Bouys, L., Chasseloup, F., Kamenický, P., & Lacroix, A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac034 · Cited by 100
Functioning Pituitary Adenomas – Current Treatment Options and Emerging Medical Therapies
Varlamov, E. V., McCartney, S., & Fleseriu, M. (2019) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2019.15.1.30 · Cited by 99
Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies
Ito, T., Lee, L., & Jensen, R. T. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1236916 · Cited by 98
Management of functional neuroendocrine tumors of the pancreas
Öberg, K. (2018) · Gland Surgery · doi:10.21037/gs.2017.10.08 · Cited by 98
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of Cushing's syndrome
Newell-Price, J. D. C., Nieman, L. K., Reincke, M., & Tabarin, A. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0352 · Cited by 97
Self-citationPlasma Steroid Metabolome Profiling for Diagnosis and Subtyping Patients with Cushing Syndrome
Eisenhofer, G., Masjkur, J., Peitzsch, M., Di Dalmazi, G., Bidlingmaier, M., Grüber, M., Fazel, J., Osswald, A., Beuschlein, F., & Reincke, M. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2017.282582 · Cited by 96
Serum cortisol: an up-to-date assessment of routine assay performance
Hawley, J. M., Owen, L. J., Lockhart, S. J., Monaghan, P. J., Armston, A., Chadwick, C. A., Wilshaw, H., Freire, M., Perry, L., & Keevil, B. G. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.255034 · Cited by 95
A clinical perspective on ectopic Cushing’s syndrome
Ragnarsson, Ó., Juhlin, C. C., Torpy, D. J., & Falhammar, H. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.12.003 · Cited by 95
Valassi, E., Tabarin, A., Brue, T., Feelders, R. A., Reincke, M., Netea-Maier, R., Tóth, M., Zacharieva, S., Webb, S. M., Tsagarakis, S., et al. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0464 · Cited by 94
Self-citationCushing's syndrome: Treatment and new therapeutic approaches
Ferrière, A., & Tabarin, A. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101381 · Cited by 90
Self-citationNieman, L. K., Castinetti, F., Newell-Price, J. D. C., Valassi, E., Drouin, J., Takahashi, Y., & Lacroix, A. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00588-w · Cited by 88
Self-citationLongitudinal patterns of recurrence in patients with adrenocortical carcinoma
Glenn, J. A., Else, T., Hughes, D. T., Cohen, M. S., Jolly, S., Giordano, T. J., Worden, F. P., Gauger, P. G., Hammer, G. D., & Miller, B. S. (2018) · Surgery · doi:10.1016/j.surg.2018.04.068 · Cited by 88
Fleseriu, M., & Castinetti, F. (2016) · Pituitary · doi:10.1007/s11102-016-0742-1 · Cited by 87
Diagnosis and management of primary bilateral macronodular adrenal hyperplasia
Vassiliadi, D. A., & Tsagarakis, S. (2019) · Endocrine Related Cancer · doi:10.1530/erc-19-0240 · Cited by 87
Pivonello, R., Bancos, I., Feelders, R. A., Kargi, A. Y., Kerr, J. M., Gordon, M. B., Mariash, C. N., Terzolo, M., Ellison, N., & Moraitis, A. G. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.662865 · Cited by 87
Long‐term morbidity and mortality in patients with Cushing's syndrome
Braun, L. T., Vogel, F., & Reincke, M. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13113 · Cited by 86
Marques, P., Caimari, F., Hernández-Ramírez, L. C., Collier, D., Iacovazzo, D., Ronaldson, A., Magid, K. S., Lim, C. T., Stals, K. L., Ellard, S., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa040 · Cited by 86
Recent Updates on the Diagnosis and Management of Cushing's Syndrome
Nieman, L. K. (2018) · Endocrinology and Metabolism · doi:10.3803/enm.2018.33.2.139 · Cited by 85
Self-citationPituitary Adenomas: From Diagnosis to Therapeutics
Banskota, S., & Adamson, D. C. (2021) · Biomedicines · doi:10.3390/biomedicines9050494 · Cited by 85
Approach to the Patient Treated with Steroidogenesis Inhibitors
Castinetti, F., Nieman, L. K., Reincke, M., & Newell-Price, J. D. C. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab122 · Cited by 83
Self-citationDormoy, A., Haissaguerre, M., Vitellius, G., Cao, C. D., Geslot, A., Drui, D., Lasolle, H., Vieira-Pinto, O., Salenave, S., François, M., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac691 · Cited by 82
Self-citationDopamine agonist resistant prolactinomas: any alternative medical treatment?
Souteiro, P., & Karavitaki, N. (2019) · Pituitary · doi:10.1007/s11102-019-00987-3 · Cited by 81
Molecular and Clinical Spectrum of Primary Hyperparathyroidism
Jha, S., & Simonds, W. F. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad009 · Cited by 80
An individualized approach to the management of Cushing disease
Fleseriu, M., Varlamov, E. V., Hinojosa‐Amaya, J. M., Langlois, F., & Melmed, S. K. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00868-7 · Cited by 80
Metyrapone treatment in Cushing’s syndrome: a real-life study
Ceccato, F., Zilio, M., Barbot, M., Albiger, N. M. E., Antonelli, G., Plebani, M., Watutantrige‐Fernando, S., Sabbadin, C., Boscaro, M., & Scaroni, C. M. (2018) · Endocrine · doi:10.1007/s12020-018-1675-4 · Cited by 79
Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives
Herrera-Martínez, A. D., Hofland, J., Hofland, L. J., Brabander, T., Eskens, F. A. L. M., Moreno, M. Á. G., Luque, R. M., Castano, J. P., de Herder, W. W., & Feelders, R. A. (2018) · Drugs · doi:10.1007/s40265-018-1033-0 · Cited by 78
Glucocorticoids and cognitive function: a walkthrough in endogenous and exogenous alterations
Alcubierre, D. D., Ferrari, D., Mauro, G. C. D., Isidori, A. M., Tomlinson, J., & Pofi, R. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02091-7 · Cited by 78
Hurtado, M. D., Cortes, T., Natt, N., Young, W. F., & Bancos, I. (2018) · Clinical Endocrinology · doi:10.1111/cen.13803 · Cited by 76
Carroll, T. B., Peppard, W. J., Herrmann, D. J., Javorsky, B. R., Wang, T. S., Patel, H., Zarnecki, K., & Findling, J. W. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2018-00269 · Cited by 76
Self-citationQuality of Life in Patients With Cushing's Disease
Vives, A. S., Resmini, E., Martínez-Momblán, M.-A., Valassi, E., Martel‐Duguech, L., & Webb, S. M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00862 · Cited by 76
Diabetes Mellitus Secondary to Cushing’s Disease
Barbot, M., Ceccato, F., & Scaroni, C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00284 · Cited by 75
Vassiliadi, D. A., & Tsagarakis, S. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0007 · Cited by 75
Hunt, H., Belanoff, J. K., Walters, I. A. S., Gourdet, B., Thomas, J. A., Barton, N., Unitt, J. F., Phillips, T., Swift, D., & Eaton, E. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00162 · Cited by 75
Lu, Z., Zheng, H., Chen, Z., Xu, S., Chen, S., Mi, W., Wang, T., Chai, X., Guo, Q., Zhou, H., et al. (2022) · JAMA Surgery · doi:10.1001/jamasurg.2022.3338 · Cited by 73
Liu, Y., Liu, X.-H., Hong, X., Liu, P., Bao, X., Yao, Y., Xing, B., Yan-sheng, L., Huang, Y., Zhu, H., et al. (2019) · Neuroendocrinology · doi:10.1159/000496753 · Cited by 73
Bilateral adrenalectomy in the 21st century: when to use it for hypercortisolism?
Guerin, C., Taieb, D., Treglia, G., Brue, T., Lacroix, A., Sebag, F., & Castinetti, F. (2016) · Endocrine-Related Cancer · doi:10.1530/erc-15-0541 · Cited by 69
Genetic and Epigenetic Causes of Pituitary Adenomas
Chang, M., Yang, C., Bao, X., & Wang, R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.596554 · Cited by 69
Cébula, H., Baussart, B., Villa, C., Assié, G., Boulin, A., Foubert, L., Aldéa, S., Bennis, S., Bernier, M., Proust, F., et al. (2017) · Acta Neurochirurgica · doi:10.1007/s00701-017-3140-1 · Cited by 69
Fleseriu, M., Hamrahian, A. H., Hoffman, A. R., Kelly, D. F., & Katznelson, L. (2016) · Endocrine Practice · doi:10.4158/ep161512.dscr · Cited by 68
Suarez, M. G., Stack, M., Hinojosa-Amaya, J. M., Mitchell, M. D., Varlamov, E. V., Yedinak, C. G., Cetas, J. S., Sheppard, B., & Fleseriu, M. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvz033 · Cited by 68
The Low-Renin Hypertension Phenotype: Genetics and the Role of the Mineralocorticoid Receptor
Baudrand, R., & Vaidya, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020546 · Cited by 68
Lorenz, K., Langer, P., Niederle, B., Alesina, P. F., Holzer, K., Nies, C., Musholt, T., Goretzki, P. E., Rayes, N., Quinkler, M. O., et al. (2019) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-019-01768-z · Cited by 68
Nishioka, H., & Yamada, S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111951 · Cited by 65
“Clinical practice guidelines suggest that etomidate is useful for patients with life-threatening hypercortisolemia who cannot take oral medications [242].”
BackgroundGlucocorticoid excess and COVID-19 disease
Guarnotta, V., Ferrigno, R., Martino, M., Barbot, M., Isidori, A. M., Scaroni, C. M., Ferrante, A., Arnaldi, G., Pivonello, R., & Giordano, C. S. D. S. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09598-x · Cited by 65
Dabrh, A. M. A., Ospina, N. S., Nofal, A. A., Farah, W. H., Barrionuevo, P., Sarigianni, M., Mohabbat, A. B., Benkhadra, K., Leon, B. G. C., Gionfriddo, M. R., et al. (2016) · Endocrine Practice · doi:10.4158/ep15922.ra · Cited by 65
Self-citationGlucocorticoid Withdrawal Syndrome following treatment of endogenous Cushing Syndrome
He, X., Findling, J. W., & Auchus, R. J. (2022) · Pituitary · doi:10.1007/s11102-022-01218-y · Cited by 64
Self-citation
Metadata
- Authors
- Nieman, L. K., Biller, B. M. K., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., & Tabarin, A.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-08
- Volume
- 100
- Issue
- 8
- Pages
- 2807-2831
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC4525003
- OpenAlex
- W2127952551
- Semantic Scholar
- 4d26bfff9a2f2ea132ea661d03d84dc8b2293884
- Cited by
- 1,270
- References
- 213
- Citations by year
- 2026: 99 · 2025: 120 · 2024: 104 · 2023: 117 · 2022: 148 · 2021: 169 · 2020: 116 · 2019: 112 · 2018: 116 · 2017: 83 · 2016: 75 · 2015: 6
- FWCI
- 80.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Keywords
- Cushing's syndrome, hypercortisolism, surgical resection, bilateral adrenalectomy, radiotherapy, corticotropinoma, comorbidity management, treatment selection
- MeSH terms
- Adrenal Gland Neoplasms, Adrenalectomy, Cushing Syndrome, Endocrinology, Humans, Patient Care Planning, Pituitary Neoplasms, Recurrence, Remission Induction, Evidence-Based Medicine, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.